$ICL

ICL reported Q2 2026 sales of $2.1 billion, up 17% from $1.8 billion a year earlier, citing stronger pricing and demand. Operating income rose to $266 million from $181 million, and net income to $137 million from $93 million. Adjusted EBITDA was $448 million. ICL reiterated FY2026 adjusted EBITDA guidance of $1.5 billion to $1.7 billion and potash volumes of 4.5 to 4.7 million metric tons.

ICL Group reported Q2 2026 sales of $2.1 billion, up 17%, and adjusted EBITDA of $448 million, up 28%, citing higher potash, bromine and phosphate prices. Adjusted net income rose 35% to $149 million, and adjusted EPS rose 33% to $0.12. Free cash flow was $94 million. Full-year 2026 EBITDA guidance was reiterated at $1.5 billion to $1.7 billion.

ICL Group (NYSE: ICL) reported Q2 2026 results for the quarter ended June 30, 2026. Consolidated sales rose to $2.1 billion (+17% Y/Y). Operating income increased to $266 million from $181 million, and net income attributable to shareholders rose to $137 million from $93 million. ICL reiterated FY2026 adjusted EBITDA guidance of $1.5B to $1.7B and expects potash volumes of 4.5 to 4.7 million metric tons.

The article says ICL Group (formerly Israel Chemicals) canceled a planned $574 million St. Louis EV battery materials plant after the Trump administration withdrew a pledged $197 million. It also reports that St. Louis approved tax incentives for an ICL facility, citing Defense Department contracts linking the plant to white phosphorus supply. Bayer says it sells only limited third-party elemental phosphorus, not for military use.

Israel’s Tel Aviv Stock Exchange was flat after a late rally. TA-35 rose 0.07% to 4,058.08 and TA-125 fell 0.07% to 4,004.34. Oil & Gas gained 2% led by Delek Group (DELKG) up 4.44% after a Delek Initiatives spin-off. Turnover was NIS 3.60B equities and NIS 3.52B bonds. Shekel strengthened vs dollar and euro.

SOMO, a Dutch watchdog, says the Netherlands received €44.9 billion of Israeli capital in 2024 and invested €27.3 billion into Israel, much routed through Dutch holding companies with limited local activity. It cites Rafael’s “letterbox” holding via Ercas BV and mentions Teva, ICL, Elbit, Check Point and Palo Alto Networks. SOMO urges Dutch sanctions and possible end of the 1973 tax treaty.

Israeli sanitaryware maker Hamat said it will shut down MCP, its ceramic sanitaryware unit in Izmir, citing difficulties marketing in Turkey and other markets. The move follows Israel’s broader reduction of direct ties with Turkish industry amid political tensions. Globes reports 2025 imports from Turkey fell to $924.1m from ~$2bn in 2024, while exports dropped to $10.9m from $598.6m.

Israel and Iran reportedly agreed to stop hostilities under US pressure, helping the Tel Aviv Stock Exchange rebound from early losses. The TA-35 rose 0.33% to 4,281.85 and TA-125 rose 0.01% to 4,232.14; BlueTech Global fell 0.86% to 696.72. Insurance gained 2.2%; TelBond 60 was flat. Turnover: NIS 4.80b equities, NIS 5.43b bonds. Shekel strengthened to NIS 2.943/$ and NIS 3.39/€.

The article analyzes ICL Group Ltd.'s financial performance, focusing on its revenue breakdown, profitability margins, and competitor comparison within the Agricultural Chemicals industry. It highlights that Phosphate Solutions is ICL's largest revenue contributor, and the company maintains a gross margin of 27.51% despite negative operating and net margins. ICL's financial metrics are benchmarked against industry peers like MOS and SMG to provide context for its market valuation.

Y.D. More Investments Ltd increased its stake in ICL Group Ltd. (ICL) by 5.5% in Q4, making it their 5th largest holding, valued at $107.5 million. ICL reported Q4 EPS in line with estimates at $0.09 but missed revenue forecasts at $1.70 billion, while analysts maintain a "Hold" rating with an average price target of $6.10. The company currently trades near $5.24, has a market cap of $6.76 billion, and offers an annualized dividend of $0.19, yielding approximately 3.6%.